Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Scientific Reports
|
February 7, 2020
Nerve damage induced skeletal muscle atrophy is associated with increased accumulation of intramuscular glucose and polyol pathway intermediates
Henning Tim Langer, Shoaib Afzal, Stefan Kempa, et al.
Nature Reviews. Endocrinology
|
May 17, 2024
AMPK as a mediator of tissue preservation: time for a shift in dogma?
Henning Tim Langer, Maria Rohm, Marcus DaSilva Goncalves, et al.
Cells
|
October 15, 2025
Correction: Li et al. Age-Associated Differences in Recovery from Exercise-Induced Muscle Damage. <i>Cells</i> 2024, <i>13</i>, 255
Donna Ching Wah Li, Stefan Rudloff, Henning Tim Langer, et al.
Cells
|
February 9, 2024
Age-Associated Differences in Recovery from Exercise-Induced Muscle Damage
Donna Ching Wah Li, Stefan Rudloff, Henning Tim Langer, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 6, 2023
The proteasome regulates body weight and systemic nutrient metabolism during fasting
Henning Tim Langer, Samuel R Taylor, Mujmmail Ahmed, et al.
Frontiers in Oncology
|
June 20, 2022
Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer
Henning Tim Langer, Shakti Ramsamooj, Roger J Liang, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer
Henning Tim Langer, Shakti Ramsamooj, Ezequiel Dantas, et al.
Acta Physiologica (Oxford, England)
|
May 23, 2024
Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer
Henning Tim Langer, Shakti Ramsamooj, Ezequiel Dantas, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 6, 2025
Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans
Henning Tim Langer, Natalie K Gilmore, Chris M T Hayden, et al.
Cell Reports. Medicine
|
March 18, 2026
Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans
Henning Tim Langer, Natalie K Gilmore, Christopher M T Hayden, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Scientific Reports
|
February 7, 2020
Nerve damage induced skeletal muscle atrophy is associated with increased accumulation of intramuscular glucose and polyol pathway intermediates
Henning Tim Langer, Shoaib Afzal, Stefan Kempa, et al.
Nature Reviews. Endocrinology
|
May 17, 2024
AMPK as a mediator of tissue preservation: time for a shift in dogma?
Henning Tim Langer, Maria Rohm, Marcus DaSilva Goncalves, et al.
Cells
|
October 15, 2025
Correction: Li et al. Age-Associated Differences in Recovery from Exercise-Induced Muscle Damage. <i>Cells</i> 2024, <i>13</i>, 255
Donna Ching Wah Li, Stefan Rudloff, Henning Tim Langer, et al.
Cells
|
February 9, 2024
Age-Associated Differences in Recovery from Exercise-Induced Muscle Damage
Donna Ching Wah Li, Stefan Rudloff, Henning Tim Langer, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 6, 2023
The proteasome regulates body weight and systemic nutrient metabolism during fasting
Henning Tim Langer, Samuel R Taylor, Mujmmail Ahmed, et al.
Frontiers in Oncology
|
June 20, 2022
Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer
Henning Tim Langer, Shakti Ramsamooj, Roger J Liang, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer
Henning Tim Langer, Shakti Ramsamooj, Ezequiel Dantas, et al.
Acta Physiologica (Oxford, England)
|
May 23, 2024
Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer
Henning Tim Langer, Shakti Ramsamooj, Ezequiel Dantas, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 6, 2025
Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans
Henning Tim Langer, Natalie K Gilmore, Chris M T Hayden, et al.
Cell Reports. Medicine
|
March 18, 2026
Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans
Henning Tim Langer, Natalie K Gilmore, Christopher M T Hayden, et al.
Page
of 1